UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
February 3, 2021
Accession Number:
0000882104-21-000024
Submission Type:
POS AM
CIK:
0000882104
Company Name:
PDL BIOPHARMA, INC.
File Number:
333-125906